TGTX

TG Therapeutics Inc

Jun 05 • 04:00PM ET

40.16

-0.40 -0.99 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: INCY BMRN ACAD AXSM MDGL KRYS PTGX RYTM VKTX NBIX

| Held by: IJR VTI IWM XBI VB VBK VXF SPSM IJT IWO

Scroll to Statements

Index	RUT	P/E	14.00	EPS (ttm)	2.87	Insider Own	7.16%	Shs Outstand	153.09M	Perf Week	5.85%
Market Cap	6.15B	Forward P/E	15.86	EPS next Y	2.53	Insider Trans	0.00%	Shs Float	142.12M	Perf Month	-4.31%
Enterprise Value	6.39B	PEG	4.43	EPS next Q	0.36	Inst Own	69.14%	Short Float	19.78%	Perf Quarter	37.21%
Income	461.90M	P/S	8.78	EPS this Y	-50.18%	Inst Trans	0.84%	Short Ratio	13.60	Perf Half Y	27.05%
Sales	700.35M	P/B	10.54	EPS next Y	83.51%	ROA	42.27%	Short Interest	28.11M	Perf YTD	34.72%
Book/sh	3.81	P/C	11.95	EPS next 5Y	3.58%	ROE	112.60%	52W High	44.65 -10.06%	Perf Year	2.19%
Cash/sh	3.36	P/FCF	-	EPS past 3/5Y	- -	ROIC	34.60%	52W Low	25.28 58.86%	Perf 3Y	55.36%
Dividend Est.	-	EV/EBITDA	42.28	Sales past 3/5Y	504.86% 426.73%	Gross Margin	83.05%	Volatility	4.72% 4.00%	Perf 5Y	14.19%
Dividend TTM	-	EV/Sales	9.12	EPS Y/Y TTM	1079.73%	Oper. Margin	21.35%	ATR (14)	1.69	Perf 10Y	407.71%
Dividend Ex-Date	-	Quick Ratio	5.12	Sales Y/Y TTM	81.26%	Profit Margin	65.95%	RSI (14)	56.94	Recom	1.62
Dividend Gr. 3/5Y	- -	Current Ratio	5.81	EPS Q/Q	297.43%	SMA20	0.55%	Beta	1.67	Target Price	48.00
Payout	0.00%	Debt/Eq	1.29	Sales Q/Q	69.56%	SMA50	8.56%	Rel Volume	0.87	Prev Close	40.56
Employees	399	LT Debt/Eq	1.29	Earnings	May 06 BMO	SMA200	22.52%	Avg Volume	2.07M	Price	40.16
IPO	Dec 14, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	-56.44% 2.29%	Trades		Volume	1,789,404	Change	-0.99%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)